GB8819626D0 - Pharmaceutical composition for treatment of tumours - Google Patents

Pharmaceutical composition for treatment of tumours

Info

Publication number
GB8819626D0
GB8819626D0 GB888819626A GB8819626A GB8819626D0 GB 8819626 D0 GB8819626 D0 GB 8819626D0 GB 888819626 A GB888819626 A GB 888819626A GB 8819626 A GB8819626 A GB 8819626A GB 8819626 D0 GB8819626 D0 GB 8819626D0
Authority
GB
United Kingdom
Prior art keywords
tumours
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888819626A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Priority to GB888819626A priority Critical patent/GB8819626D0/en
Publication of GB8819626D0 publication Critical patent/GB8819626D0/en
Priority to JP1212011A priority patent/JPH02188526A/en
Priority to KR1019890011685A priority patent/KR900002779A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB888819626A 1988-08-18 1988-08-18 Pharmaceutical composition for treatment of tumours Pending GB8819626D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB888819626A GB8819626D0 (en) 1988-08-18 1988-08-18 Pharmaceutical composition for treatment of tumours
JP1212011A JPH02188526A (en) 1988-08-18 1989-08-17 Drug composition for curing of tumor
KR1019890011685A KR900002779A (en) 1988-08-18 1989-08-17 Pharmaceutical composition for tumor treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819626A GB8819626D0 (en) 1988-08-18 1988-08-18 Pharmaceutical composition for treatment of tumours

Publications (1)

Publication Number Publication Date
GB8819626D0 true GB8819626D0 (en) 1988-09-21

Family

ID=10642328

Family Applications (1)

Application Number Title Priority Date Filing Date
GB888819626A Pending GB8819626D0 (en) 1988-08-18 1988-08-18 Pharmaceutical composition for treatment of tumours

Country Status (3)

Country Link
JP (1) JPH02188526A (en)
KR (1) KR900002779A (en)
GB (1) GB8819626D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders

Also Published As

Publication number Publication date
JPH02188526A (en) 1990-07-24
KR900002779A (en) 1990-03-23

Similar Documents

Publication Publication Date Title
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
ZA883850B (en) Treatment of materials
CY1600A (en) Pharmaceutical composition
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
IL86753A0 (en) Pharmaceutical compositions for treatment of lupus
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
IL87182A0 (en) Pharmaceutical compositions containing tumor necrosis factor for treating infections
AU1541088A (en) Composition for the treatment of the epiderm
IL95245A0 (en) Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
AU3510489A (en) Pharmaceutical composition for treating tumor
EP0333490A3 (en) Composition for the treatment of hepatopathy composition for the treatment of hepatopathy
GB2220652B (en) Treatment of pastures
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
GB8713306D0 (en) Materials for treatment of tumours
RO92740B1 (en) Medicinal composition for the treatment of otites
GB8709861D0 (en) Pharmaceutical compositions & treatment
GB8709862D0 (en) Pharmaceutical compositions & treatment
GB8709860D0 (en) Pharmaceutical compositions & treatment
GB8811716D0 (en) Pharmaceutical compositions & treatment
GB8809329D0 (en) Pharmaceutical compositions & treatment
GB8811718D0 (en) Pharmaceutical compositions & treatment